Insulin, insulin sensitivity and hypertension

Journal of Hypertension

Volumn 8, Issue 6, 1990, Pages 491-500

  Ferrari, Paolo ^a   Weidmann, Peter ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Diabetes; Hyperinsulinaemia; Hypertension; Impaired glucose tolerance; Insulin resistance; Obesity; Pathophysiology

Indexed keywords

INSULIN; SODIUM;

BLOOD PRESSURE; DIABETES MELLITUS; ELECTROLYTE BALANCE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERINSULINISM; HYPERTENSION; INSULIN RESISTANCE; METABOLISM; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; ESSENTIAL HYPERTENSION; HYPERINSULINEMIA; INSULIN SENSITIVITY;

BLOOD GLUCOSE; BLOOD PRESSURE; DIABETES MELLITUS; HUMAN; HYPERINSULINISM; HYPERTENSION; INSULIN; INSULIN RESISTANCE; OBESITY; SODIUM; SUPPORT, NON-U.S. GOV'T; WATER-ELECTROLYTE BALANCE;

EID: 0025441454     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/00004872-199006000-00001     Document Type: Article

References (131)

1. Christlieb AR, Krolewsky AS, Warram JH, Soeldner JS: Is insulin the link between hypertension and obesity? Hyper tension 1985, 7 (suppl II):II54-II57.
2. Modan M, Halkin H, Almog S, et al.: Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest 1985, 75:809-817.
3. Landsberg L Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 236:1081-1090.
4. Ferranini E, Buzzigou G, Giorico MA, et al: Insulin resistance in essential hypertension. N Engl J Med 1987, 317:350-357.
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 1988, 37:1595-1607.
6. Zavaroni I, Bonora E, Paguara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 1989, 320:702-706.
7. Tobey TA, Greenfield M, Kraemer F, Reaven GM: Relationship between insulin resistance, insulin secretion, very low density lipoprotein kinetics, and plasma triglyceride levels in normotriglyceridemic man. Metabolism 1981, 30:165-171.
8. Srinivasan SR, Webber LS, Berensen GS: The relationship between very low density lipoprotein lipids and measures of carbohydrate metabolism in children with different lipoprotein profiles: Bogalusa heart study. Metabolism 1984, 33:760-767.
9. Abbott WGH, Liuioja S, Young AA, et al: Relationships between plasma lipoprotein concentrations and insulin action in obese hyperinsulinemic population. Diabetes 1987, 36:897-904.
10. STAMLER R, STAMLER J, RIEDLINGER WF, ALGERA G, ROBERTS RH: Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA 1978, 240:1607-1610.
11. Florey C du V, Uppal S, Low C: Relation between blood pressure, weight, and plasma sugar and serum insulin levels in schoolchildren aged 9-12 years in Westland, Holland. Br MedJ 1976, 1:1368-1371.
12. Jarret RJ, Keen H, McCartney M, et al.: Glucose tolerance and blood pressure in two population samples: their relation to diabetes mellitus and hypertension. Int J Epidemiol 1978, 7:15-24.
13. STAMLER J, RHOMBERG P, SCHOENBERGER JA, et al: Multivariate analysis of the relationship of seven variables to blood pressure: findings of the Chicago Heart Association detection project in industry, 1967-1972. J Chronic Dis 1975, 28:527-528.
14. National Diabetes Data Group: Summary. In Diabetes in America edited by the National Diabetes Data Group. Washington, DC: US Department of Health and Human Services, publication 85 1468, 1985, pp 1-6.
15. The Working Group on Hypertension in Diabetes: Statement on hypertension in diabetes mellitus: final report. Arch Intern Med 1987, 147:830-842.
16. Krolewsky AS, Canessa M, Warram JH: Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1988, 318:140-145.
17. De Fronzo RA, Hendler R, Simonson D: Insulin resistance is a prominent feature of insulin-dependent diabetes. Diabetes 1982, 31:795-801.
18. Yki-JÄrvinen H, Koivisto V: Natural course of insulin resistance in type 1 diabetes. N Engl J Med 1986, 315:224-230.
19. Muggeo M, Bar RS, Roth J, Kahn CR: Two abnormalities in insulin binding to its receptor in the insulin resistance of acromegaly [abstract]. Clin Res 1978, 26:310A.
20. Reza RA, Mandarino LJ, Gerich JE: Cortisol-induced insulin resistance in man: impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor defect of insulin action. J Clin Endocrinol Metab 1982, 54:131-138.
21. Nosadini R, Del Prato S, Tiengo A, et al.: Insulin resistance in Cushing’s syndrome. J Clin Endocrinol Metab 1983, 57:529-536.
22. Ryan EA, O’Sullivan MJ, Skyler JS: Insulin action during pregnancy: studies with the eugtycemic clamp technique. Diabetes 1985, 34:380-389.
23. Avogaro A, Fontana P, Valerio A, et al: Alcohol impairs insulin resistance in normal subjects. Diabetes Res 1987, 5:23-27.
24. Cohen CJ, Hickman R: Insulin resistance and diminished glucose tolerance in powerlifters ingesting anabolic steroids. J Clin Endocrinol Metab 1987, 64:960-963.
25. Kasdorf G, Kalkhoff RK: Prospective studies of insulin sensitivity in normal women receiving oral contraceptive agents. J Clin Endocrinol Metab 1988, 66:846-852.
26. Schmitz O: Peripheral and hepatic resistance to insulin and hepatic resistance to glucagon in uremic subjects. Acta Endocrinol (Copenh) 1988, 118:125-134.
27. Wessels F, Wagner H, Zierden E: The relevance of intracellular electrolyte metabolism in the impaired glucose tolerance of patients with hypertension (in German). Verb Dtscb Ges Inn Med 1974, 80:295-298.
28. Pollare T, Lithell H, Berne C: A comparison of the effects of hydrochlorothiazide and captopril on glucose and lipid metabolism in patients with hypertension. N Engl J Med 1989, 321:868-873.
29. Cerasi E, Luft R, Efendic S: Effects of adrenergic-blocking agents on insulin response to glucose infusion in man. Acta Endocrinol (Scand) 1972, 69:335-346.
30. WILIIam-Olsson T, Fellenius E, BjÖrntorp P, Smith U: Differences in metabolic responses to β-adrenergic stimulation after propranolol or metoprolol administration. Acta Med Scand 1979, 205:201-206.
31. Pollare T, Lithell H, SeLInus I, Berne C: Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized, double blind study of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. Br Med J 1989, 298:1152-1157.
32. Wright AD, Barber SG, Kendall MJ, Poole PH: Betaadrenoceptor-blocking drugs and blood sugar control in diabetes mellitus. Br Med J 1979, 278:159-161.
33. Bengtsson C, Blohme G, Lapidus L, et al: Do antihypertensive drugs precipitate diabetes? Br Med J 1984, 289:1495-1497.
34. Skarfors ET, Lithell HO, Seunus I, Aberg H: Do antihypertensive drugs precipitate diabetes in predisposed men? Br MedJ 1989, 298:1147-1152.
35. Mondon CE, Reaven GM: Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metabolism 1988, 37:303-305.
36. Reaven GM, Chang H, Hoffman BB, Azhar S: Resistance to insulin-stimulated glucose uptake in adipocytes isolated from spontaneously hypertensive rats. Diabetes 1989, 38:1155-1160.
37. Eriksson J, Franssila-Kallunki A, Ekstrand A, et al: Early metabolic defects in persons at increased risk for noninsulin dependent diabetes mellitus. N Engl J Med 1989, 321:337-343.
38. Ferrari P, Giachino D, Weidmann P, Keller U, RIEsen W, Shaw S: Insulin sensitivity and lipoproteins in hypertension-prone man [abstract]. Kidney Int 1990, 38:1172.
39. Wagner H, Wessels F, Zierden E, Jung-HÜlsing G: Assessment of insulin and glucose metabolsm in hypertension (in German). Verb Dtscb Ges Inn Med 1971, 77:133-136.
40. TSUTSU N, NUNOI K, KODAMA T, NOMTVAMA R, IWASE M, FujisHIma M: Lack of association between blood pressure and insulin in patients with insulinoma. J Hypertens 1990, 8:479-482.
41. Bar RS, Gorden P, Roth J: Insulin receptors in patients with insulinomas. J Clin Endocrinol Metab 1977, 44:1210-1215.
42. Takayama S, Kahn RC, Kubo K, Foley JE: Alterations in insulin receptor autophosphorylation in insulin resistance: correlation with altered sensitivity to glucose transport and antilipolysis to insulin. J Clin Endocrinol Metab 1988, 66:992-999.
43. Eckel RH: Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N Engl J Med 1989, 320:1060-1068.
44. Abrams JJ, Ginsberg H, Grundy SM: Metabolism of cholesterol and plasma triglycerides in nonketotic diabetes mellitus. Diabetes 1982, 31:903-910.
45. TasKInen MR, KUUSI T, Helve E, NkkilÄ EA, Yki JÄrvinen H: Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes. Arteriosclerosis 1988, 8:168-177.
46. Oppenheimer MJ, Sundquist K, Bœrman EL Downregulation of high density lipoprotein receptor activity of cultured fibroblasts by insulin and IGF-I. Diabetes 1989, 38:117-122.
47. Stout RW: Development of vascular lesions in insulintreated animals fed a normal diet. Br Med J 1970, 3:685-687.
48. Stamler J, Pick R, Katz LN: Effect of insulin in the induction and regression of atherosclerosis in the chicken. Circ Res 1960, 8:572-576.
49. 14C into lipids of the rat aorta in vivo. Horm Metab Res 1975, 7:31-34.
50. Nakao J, Ito H, Kanayasu T, Murota SI: Stimulatory effect of insulin on aortic smooth muscle cell migration induced by 12-L-hydroxy-5,8,10, l4 eicosatetraenoic acid and its modulation by extracellular glucose levels. Diabetes 1985, 34:185-191.
51. Juhan-Vague I, Alessi MC, Joly P, et al: Plasma plasminogen activator inhibitor-1 in angina pectoris: influence of plasma insulin and acute-phase response. Arteriosclerosis 1989, 9:362-367.
52. Caste III WP, Abbott RD, McNamara PM: Summary estimates of cholesterol used to predict coronary heart disease. Circulation 1983, 67:730-734.
53. Stout KW, Bierman EL, Ross R: The effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res 1975, 36:319-327.
54. Pfeifle B, Ditschuneit H: Effect of insulin on growth of cultured human arterial smooth muscle cells. Diabetologia 1981, 20:155-158.
55. King GL, Kahn CR, Rechler MM, Nissley SP: Direct demonstration of separate receptors for growth and metabolic activities of insulin and multiplication-stimulating activity (an insulin-like growth factor) using antibodies to the insulin receptor. J Clin Invest 1980, 66:130-140.
56. Moore RD: Effects of insulin upon ion transport. Biocbim Biopbys Acta 1983, 737:1-49.
57. Clausen T, Kohn PG: The effect of insulin on the transport of sodium and potassium in rat soleus muscle. J Physiol (Lond) 1977, 265:19-42.
58. +)-ATPase extracted from frog skeletal muscle. J Physiol (Lond) 1975, 252:43-58.
59. Moore RD, Munford JW, POPOLIZIO M: Effect of streptozotocin-induced diabetes upon intracellular sodium in rat skeletal muscle. FEBS Lett 1979, 106:375-378.
60. Moore RD, Fidelman ML, Seeholzer SH: Correlation between insulin action upon glycotysis and change in intracellular pH. Biocbem Biopbys Res Commun 1979, 91:905-910.
61. Fidelman ML, Seeholzer SH, Walsh KB, Moore RD: Intracellular pH mediates action of insulin on giycotysis in frog skeletal muscle. Am J Physiol 1982, 242:C87-C93.
62. Muluns LJ: Steady-state calcium fluxes: membrane versus mitochondrial control of ionized calcium in axoplasm. Fed Proc 1976, 35:2583-2588.
63. Muluns LJ: A mechanism for Na/Ca transport. J Gen Physiol 1977, 70:681-695.
64. Eddy AA: The amino acid pumps of living cells. Sci Proc Oxf 1981, 67:245-270.
65. Crane RK: The gradient hypothesis and other models of carrier-mediated active transport. Rev Physiol Biochem Pharmacol 1977, 78:99-159.
66. + transport in cultured kidney cells (A6). Endocrinology 1984, 115:1171-1178.
67. Saudek CD, Boulter PR, Knopp RH, Arky RA: Sodium retention accompanying insulin treatment of diabetes mellitus. Diabetes 1974, 23:240-246.
68. De Fronzo RA: The effect of insulin on renal sodium metabolism. Diabetologia 1981, 21:165-171.
69. Hall JE, Coleman TG, Mizelle HL: Does chronic hyperinsulinetnia cause hypertension? Am J Hypertens 1989, 2:171-173.
70. Rocchini A, Kvesaus D, Moorehead C: Insulin and renal sodium handling in obese adolescents: a cause of hypertension [abstract]. Hypertension 1987, 10:358.
71. Wiseman MJ, Mangw R, Alberetto M, Keen H, Viberti G: Glomerular response mechanisms to glycemic changes in insulin-dependent diabetes. Kidney Int 1987, 31:1012-1018.
72. Ullrich KJ: Renal tubular mechanisms of organic solute transport. Kidney Int 1976, 9:134-148.
73. Harris RC, Brenner BM, Scifert JL: Sodium-hydrogen exchange and glucose transport in renal microvillus membrane vesicles from rats with diabetes mellitus. J Clin Invest 1986, 77:724-733.
74. Kumar AM, Gupta RK, Spitzer A: Intracellular sodium in proximal tubules of diabetic rats: role of glucose. Kidney Int 1988, 33:792-797.
75. Clausen T: The effect of insulin on glucose transport in muscle cells. In Current Topics in Membranes and Transport. San Francisco: Academic Press, 1975, pp 169-226.
76. Elbring J, Bihler I: Membrane transport: its relation to cellular metabolic rates. Science 1975, 188:1177-1184.
77. McDonald JM, Bruns DE, Jarett L The ability of insulin to alter the stable calcium pools of isolated adipocyte subcellular fractions. Biochem Biopbys Res Commun 1976, 71:114-121.
78. Schudt C, Gaertner U, Pette D: Insulin action on glucose transport and calcium fluxes in developing muscle cells in vitro. Eur J Biochem 1976, 68:103-111.
79. 2+ -ATPase in isolated adipocyte plasma membranes. Nature 1979, 281:495-497.
80. 2+)-ATPase in adipocyte plasmalemma: inhibition by insulin and concanavalin A in the intact cell. Biochem Int 1981, 2:243-248.
81. Pershadsingh HA, Shade DL, Delfert DM, McDonald JM: Chelation of intracellular calcium blocks insulin action in the adipocyte. Proc Natl Acad Sci USA 1987, 84:1025-1029.
82. Draznin B, Sussman K, Kao M, Lewis D, Shereman N: The existence of an optimal range of cytosolic free calcium for insulin-stimulated glucose transport in rat adipocytes./Biol Chem 1987, 262:14385-14388.
83. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA: Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsu-linemia. J Clin Invest 1988, 82:1848-1852.
84. Snow TR Study of the characteristics of the inotropic effect of insulin in rabbit papillary muscle. Experientia 1976, 32:1550-1551.
85. Imanaga I: Effects of insulin on mammalian cardiac muscle. In Recent Advances in Studies on Cardiac Structure and Metabolism, vol 11 edited by Kobayashi T, Sano T, Dhalla NS. Baltimore: University Park Press, 1978, pp 441-450.
86. + exchange and cytosolic pH in the action of growth factors in human fibroblasts. Nature 1983, 304:645-648.
87. Young JB, Rosa RM, Landsberg L: Dissociation of sympathetic nervous system and adrenal medullary responses. Am J Physiol 1984, 247:35-40.
88. Landsberg L, young JB: Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 1985, 9 (suppl 2):63-68.
89. Berglund G, Andersson O: Body composition, metabolic and hormonal characteristics in unselected male hypertensives. Int J Obes 1981, 5 (suppl 1):143-150.
90. Rowe JW, Young JB, MInaker KL, Stevens AL, Pallotta J, Landsberg L: Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981, 20:219-225.
91. Landsberg L Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. Q J Med 1986, 236:1081-1090.
92. O’Hare JA, Minaker K, Young JB, Rowe JW, Pallotta JA, Landsberg L: Insulin increases plasma norepinephrine (NE) and lowers plasma potassium equally in lean and obese men [abstract]. Clin Res 1985, 33:441A.
93. Beretta-Piccou C, Fischbacher A, Rothenbüler A, Gerber A, Weidmann P: Sodium-blood volume state in normoten-sive members of normotensive or hypertensive families. J Hypertens 1986, 4 (suppl 6):S310-S313.
94. Weidmann P, Hirsch D, Beretta Piccou C, Ziegler WH, Reubi FC: Interrelations among blood pressure, blood volume, plasma renin activity and urinary catecholamines in benign essential hypertension. Am J Med 1977, 62:209-218.
95. Beretta PiccoLI C, Davies DL, Boddy K, et al: Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci 1982, 63:257-270.
96. Messeru FH, Christie B, De Carvalho J, et al: Obesity and essential hypertension: hemodynamics, intravascular volume, sodium excretion, and plasma renin activity. Arch Intern Med 1981, 141:81-85.
97. BOEHRINGER K, BERETTA-PICCOU C, WEIDMANN P, MEIER A, Ziegler WH: Pressor factors and cardiovascular pressor responsiveness in lean and overweight normal or hypertensive subjects. Hypertension 1982, 4:697-702.
98. De Châtel R, Weidmann R, Fiammer J, et al: Sodium, renin, aldosterone, catecholamines and blood pressure in diabetes mellitus. Kidney Int 1977, 12:412-421.
99. Weidmann P, BerettaPiccou C, Trost RN: Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985, 7 (suppl II):II33-II42.
100. Feldt-Rasmussen B, Mathiesen ER, Deckert T, et al: Central role for sodium in the pathogenesis of blood pressure changes independent of angiotensin, aldosterone and catecholamines in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1987, 30:610-617.
101. Canessa M, Adragna N, Solomon HS, Conolly TM, Tosteson DC: Increased sodium-lithium countertransport in red cells of patients with essential hypertension. N Engl J Med 1980, 302:772-776.
102. Sempljcini A, Mozzato MG, Samà B, et al: Na/H and Li/Na exchange in red blood cells of normotensive and hypertensive patients with insulin dependent diabetes mellitus (IDDM). Am J Hypertens 1989, 2:174-177.
103. Garay RP, Nazaret C, Hannaert P, Price M: Abnormal Na +, K+ cotransport function in a group of patients with essential hypertension. Eur J Clin Invest 1983, 13:311-320.
104. Trevisan M, Vaccaro O, Laurenzi M, et al: Hypertension, non-insulin-dependent diabetes, and intracellular sodium metabolism. Hypertension 1988, 11:264-268.
105. Zemel MB, Kraniak J, Standley PR, Sowers JR: Erythrocyte metabolism in salt-sensitive blacks as affected by dietary sodium and calcium. Am J Hypertens 1988, 1:386-392.
106. Erne P, Bolu P, Burgisser E, Bühler F: Correlation of platelet calcium with blood pressure: effect of antihyper-tensive therapy. N Engl J Med 1984, 310:1084-1088.
107. Zemel MB, Bedford BA, Zemel PC, Marwah O, Sowers JR: Altered cation transport in non-insulin-dependent diabetic hypertension: effect of dietary calcium. J Hypertens 1988, 6 (suppl 4):S228-S230.
108. Weidmann P: Pathogenesis of hypertension accompanying diabetes mellitus. Contrib Nepbrol 1989, 73:73-90.
109. Ejarque P, Marble A, Tuller EF: Protein, lipoprotein and protein-bound carbohydrate in the serum of diabetic patients. Am J Med 1959, 27:221-230.
110. O’Hare JA, Ferriss JB, Brady D, Twomey B, O’Sulltvan DJ: Exchangeable sodium and renin in hypertensive diabetic patients with and without nephropathy. Hypertension 1985, 7 (suppl II):II43-II48.
111. Ferriss JB, O’Hare JA, Kelleher CCM, et al: Diabetic control of renin-angiotensin system, catecholamines, blood pressure. Hypertension 1985, 7 (suppl II):II58-II63.
112. Sawicki PT, Heinemann L, Rave K, Hohmann A, Berger M: Atrial natriuretic factor in various stages of diabetic nephropathy. J Diabetic Complications 1988, 2:207-209.
113. Reubi FC, Weidmann P, Hodler J, Cottier PT: Changes in renal function in essential hypertension. Am J Med 1978, 64:556-563.
114. Roland JM, O’Hare JP, Valters G, Corrall RJM: Sodium retention in response to saline infusion in uncomplicated diabetes mellitus. Diabetes Res 1986, 3:213-215.
115. Berne C, Fagius J: Sympathetic response to oral carbohydrate administration: evidence from microelectrode nerve recordings. J Clin Invest 1989, 84:1403-1409.
116. Landsberg L, Young JB: Insulin-mediated glucose metabolism in the relationship between dietary intake and sympathetic nervous system activity. Int J Obes 1985, 9:63-68.
117. Hwang IS, Ho H, Hoffman BB, Reaven GM: Fructose-induced insulin resistance and hypertension in rats. Hypertension 1987, 10:512-516.
118. Reisin E, Abel R, Modan M, Silverberg DS, Euahou HE, Modan B: Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med 1978, 298:1-6.
119. De Fronzo RA, Soman V, Sherwin RS, Handler R, Feug P. Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 1978, 62:204-213.
120. Reisin E, Fröhlich ED, Messeru FH, et al: Cardiovascular changes after weight reduction in obesity hypertension. Ann Intern Med 1983, 98:315-319.
121. Sowers JR, Nyby M, Stern N, et al: Blood pressure and hormone changes associated with weight reduction in the obese. Hypertension 1982, 4:686-691.
122. Phillip Th, Distler A, Cordes U: Sympathetic nervous system and blood pressure control in essential hypertension. Lancet 1978, ii:959-963.
123. Weidmann P, Keusch G, Flammer J, Ziegler WH, Reubi FC: Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension. J Clin En docrinol Metab 1979, 48:727-731.
124. Bianchetti MG, BerettaPiccou C, Weidmann P, Fermer C: Blood pressure control in normotensive members of hypertensive families. Kidney Int 1986, 29:882-888.
125. Alexander WD, Oake RJ: The effect of insulin on vascular reactivity to norepinephrine. Diabetes 1977, 26:611-614.
126. Resnik LM: Hypertension and abnormal glucose homeostasis: possible role of divalent ion metabolism. Am J Med 1989, 87 (suppl 6):6-17.
127. Reaven GM, Ho H, Hoffman BB: Somatostatin inhibition of fructose-induced hypertension. Hypertension 1989, 14:117-120.
128. Izumi Y, Honda M, Tsuchiya M, Ueda Y, Hatano M: Effects of somatostatin on plasma renin activity and blood pressure in patients with essential hypertension. Endocrinol Jpn 1980, 27:505-511.
129. Tedde R, Sechi LA, Mariguano A, Pala A, Scano L: Antihypertensive effect of insulin reduction in diabetic-hypertensive patients. Am J Hypertens 1989, 2:163-170.
130. DUCIMETIÉRE P, ESCHWEGE E, PAPOZ L, RICHARD JL, CLAUDE JR, Rosseun G: Relationship of plasma insulin levels to the incidence of myocardial infarction and coronary heart disease mortality in middle-aged population. Diabetologia 1980, 19:205-210.
131. Pyörälä K, Savolainen E, Kaukola S, Haapakoski J: Plasma insulin as coronary heart disease factor: relationship to other risk factors and predictive value during 9.5 year follow-up of the Helsinki Policemen Study Population. Acta Med Scand 1985 701 (suppl):38-52.